Activities, Bill Numbers and Titles
|
|
Client: Biotechnology Innovation Organization (BIO)
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $3,798.08
|
Senate Bill
|
2695
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1254
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
2774
|
An Act investing in the future of our health
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
771
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1224
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
House Bill
|
729
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|